Medicare Enrolled

Dr. Michael Degaetano, DO

Nephrology · San Antonio, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
5620 LONE STAR PKWY # 2, San Antonio, TX 78253
2104037978
In practice since 2006 (20 years)
NPI: 1881660454 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Degaetano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Degaetano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Degaetano

Dr. Michael Degaetano is a nephrology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Degaetano performed 4,926 Medicare services across 1,031 unique beneficiaries.

Between the years covered by Open Payments, Dr. Degaetano received a total of $12,064 from 50 pharmaceutical and/or device companies across 679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Degaetano is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 6% volume in TX $12,064 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,926
Medicare services
Top 6% in TX for nephrology
1,031
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~246 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Epoetin alfa injection (Procrit) for anemia 1,303 $6 $60
Office visit, established patient (30-39 min) 773 $70 $237
Chronic care management, first 20 min/month 767 $47 $100
Dialysis services, 4 or more physician visits per month (20 years or older) 417 $260 $649
Hospital follow-up visit, high complexity 375 $90 $200
Chronic care management, additional 20 min/month 278 $36 $75
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes 217 $30 $75
Drug injection, under skin or into muscle 161 $10 $26
Remote patient monitoring management, 20 min/month 121 $36 $93
Home dialysis services per month (20 years or older) 120 $198 $538
Remote patient monitoring device, 30 days 112 $37 $118
Blood count, hemoglobin 101 $2 $7
Initial hospital admission, high complexity 100 $133 $390
Dialysis services, 2-3 physician visits per month (20 years or older) 36 $216 $539
New patient office visit (30-44 min) 32 $73 $203
Dialysis services, 1 physician visit per month (20 years or older) 13 $154 $370
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,064
Total received (2018-2024)
Avg $1,723/year across 7 years
Top 8% in TX for nephrology
50
Companies
679
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,064 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,457
2023
$2,475
2022
$2,284
2021
$1,718
2020
$1,139
2019
$1,264
2018
$728

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,994
Daiichi Sankyo Inc.
$1,203
Amgen Inc.
$939
Fresenius USA Marketing, Inc.
$848
AKEBIA THERAPEUTICS INC
$707
Horizon Therapeutics plc
$650
Otsuka America Pharmaceutical, Inc.
$555
OPKO Pharmaceuticals, LLC
$541
Aurinia Pharma U.S., Inc.
$515
Travere Therapeutics, Inc.
$384
Relypsa, Inc.
$342
GlaxoSmithKline, LLC.
$329
Bayer Healthcare Pharmaceuticals Inc.
$298
Merck Sharp & Dohme LLC
$266
Vifor Pharma, Inc.
$238
Allergan Inc.
$217
Novartis Pharmaceuticals Corporation
$216
CALLIDITAS THERAPEUTICS US INC.
$158
CorMedix Inc.
$154
Bayer HealthCare Pharmaceuticals Inc.
$152
ANI Pharmaceuticals, Inc.
$143
Keryx Biopharmaceuticals, Inc.
$137
ARBOR PHARMACEUTICALS, INC.
$136
AbbVie Inc.
$102
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
Merck Sharp & Dohme Corporation
$76
Arbor Pharmaceuticals, Inc.
$62
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$55
Ardelyx, Inc.
$50
Exeltis, USA Inc.
$48
SHIELD THERAPEUTICS INC
$48
Outset Medical Inc
$43
Novo Nordisk Inc
$40
Takeda Pharmaceuticals U.S.A., Inc.
$31
Hikma Pharmaceuticals USA
$29
Horizon Pharma plc
$27
Pharmacosmos Therapeutics Inc.
$23
Lilly USA, LLC
$22
Abbott Laboratories
$20
Ultragenyx Pharmaceutical Inc.
$19
West-Ward Pharmaceuticals
$19
Mallinckrodt Hospital Products Inc.
$18
ABBVIE INC.
$17
Allergan, Inc.
$16
Alnylam Pharmaceuticals Inc.
$15
Shield Therapeutics Inc
$15
Calliditas Therapeutics US Inc.
$15
Retrophin, Inc.
$14
IRONWOOD PHARMACEUTICALS, INC
$14
Mallinckrodt LLC
$12
Top 3 companies account for 34.3% of total payments
Associated products mentioned in payments ›
(815) Thiola · ACCRUFER · ACTHAR · AURYXIA · AVYCAZ · Amitiza · Auryxia · BENLYSTA · BRILINTA · BYSTOLIC · CREON · CRYSVITA · DALVANCE · DefenCath · ENTRESTO · EVUSHELD · Edarbi · FARXIGA · Fabhalta · FreeStyle Libre · IBSRELA · INJECTAFER · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LOKELMA · LUPKYNIS · Linzess · MONOFERRIC · Mitigare · ONPATTRO · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · TARPEYO · TAVNEOS · TEFLARO · TERLIVAZ · TRADJENTA · TRELEGY ELLIPTA · Tavneos · Thiola · Uloric · VERQUVO · VIBERZI · Vafseo · Velphoro · Veltassa · Wegovy · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for nephrology in TX.

Equivalent to $245 per 100 Medicare services performed
Looking for a nephrology specialist in San Antonio?
Compare nephrologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
95
Per 100K population
4.7
County median income
$70,571
Nearest hospital
WESTOVER HILLS BAPTIST HOSPITAL
6.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Degaetano is a clinical cardiology specialist, with above-average Medicare volume (top 6% in TX), with low-engagement industry engagement in the top 8% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Degaetano experienced with epoetin alfa injection (procrit) for anemia?
Based on Medicare claims data, Dr. Degaetano performed 1,303 epoetin alfa injection (procrit) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Degaetano receive payments from pharmaceutical companies?
Yes. Dr. Degaetano received a total of $12,064 from 50 companies across 679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Degaetano's costs compare to other nephrologists in San Antonio?
Dr. Degaetano's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Degaetano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →